Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2025 年第 1 季持倉
持倉截至 2025/3/31，2025/5/14 申報。只含多頭部位，變化是跟 2024 年第 4 季比股數。
- 持股檔數
- 81
- 較 2024 年第 4 季 +6
- 總值
- $6.39 億
- 較 2024 年第 4 季 −$135.2 萬 (−0.2%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| XENEXenon Pharmaceuticals Inc. | COM | 1,328,175 | $4,456 萬 | 7.0% | +166,938+14.4% | 加碼 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 1,151,199 | $4,301 萬 | 6.7% | +219,471+23.6% | 加碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 615,000 | $3,905 萬 | 6.1% | −45,000−6.8% | 減碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 530,000 | $3,477 萬 | 5.4% | +105,000+24.7% | 加碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 1,000,000 | $3,302 萬 | 5.2% | −100,000−9.1% | 減碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 460,000 | $3,262 萬 | 5.1% | +175,000+61.4% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 80,000 | $2,650 萬 | 4.1% | −2,500−3.0% | 減碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,546,662 | $2,224 萬 | 3.5% | +450,738+41.1% | 加碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,400,000 | $2,152 萬 | 3.4% | 00.0% | 不變 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 400,000 | $1,934 萬 | 3.0% | +270,000+207.7% | 加碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 1,070,000 | $1,917 萬 | 3.0% | +870,000+435.0% | 加碼 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 1,100,000 | $1,747 萬 | 2.7% | +750,000+214.3% | 加碼 | 歷史 |
| SPYSPDR S&P 500 ETF Trust | ETF | 30,000 | $1,678 萬 | 2.6% | +30,000 | 新進 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 1,825,000 | $1,475 萬 | 2.3% | +325,000+21.7% | 加碼 | 歷史 |
| Omeros Corp682143AG7 | NOTE 5.250% 2/1 | – | $1,428 萬 | 2.2% | – | – | – |
| MRUSMerus N.V. | COM | 321,962 | $1,355 萬 | 2.1% | −67,279−17.3% | 減碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 100,000 | $1,166 萬 | 1.8% | +25,000+33.3% | 加碼 | 歷史 |
| Karyopharm Therapeutics Inc.48576UAA4 | NOTE 3.000%10/1 | – | $1,161 萬 | 1.8% | – | – | – |
| ESTAEstablishment Labs Holdings Inc. | COM | 280,000 | $1,143 萬 | 1.8% | +555+0.2% | 加碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 140,000 | $1,068 萬 | 1.7% | +90,000+180.0% | 加碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 300,000 | $1,037 萬 | 1.6% | +100,000+50.0% | 加碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 810,669 | $963.1 萬 | 1.5% | −129,414−13.8% | 減碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 355,143 | $853.1 萬 | 1.3% | −69,857−16.4% | 減碼 | 歷史 |
| TRVITrevi Therapeutics, Inc. | COM | 1,250,000 | $786.3 萬 | 1.2% | +1,250,000 | 新進 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 481,678 | $777.2 萬 | 1.2% | −342,650−41.6% | 減碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 430,000 | $734.9 萬 | 1.2% | +330,000+330.0% | 加碼 | 歷史 |
| Travere Therapeutics, Inc.89422GAA5 | NOTE 2.250% 3/0 | – | $699.3 萬 | 1.1% | – | – | – |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 325,000 | $665.3 萬 | 1.0% | −100,000−23.5% | 減碼 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 545,362 | $559.5 萬 | 0.9% | +176,664+47.9% | 加碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 50,000 | $553.0 萬 | 0.9% | +50,000 | 新進 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 657,154 | $526.4 萬 | 0.8% | +106,389+19.3% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 390,000 | $525.7 萬 | 0.8% | +230,386+144.3% | 加碼 | 歷史 |
| LXEOLexeo Therapeutics, Inc. | COM | 1,480,881 | $513.9 萬 | 0.8% | +1,480,881 | 新進 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 152,252 | $510.7 萬 | 0.8% | −307,748−66.9% | 減碼 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 1,700,000 | $493.0 萬 | 0.8% | +125,000+7.9% | 加碼 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 2,224,196 | $473.8 萬 | 0.7% | +924,196+71.1% | 加碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 3,045,000 | $472.0 萬 | 0.7% | −1,455,000−32.3% | 減碼 | 歷史 |
| ERASErasca, Inc. | COM | 3,341,519 | $457.8 萬 | 0.7% | +842,088+33.7% | 加碼 | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 3,284,512 | $436.8 萬 | 0.7% | +459,512+16.3% | 加碼 | 歷史 |
| QUREuniQure N.V. | SHS | 400,000 | $424.0 萬 | 0.7% | +400,000 | 新進 | 歷史 |
| FRNMFreenome, Inc. | CL A ORD SHS | 350,000 | $361.9 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 50,000 | $357.3 萬 | 0.6% | −80,000−61.5% | 減碼 | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 3,867,710 | $352.0 萬 | 0.6% | −104,608−2.6% | 減碼 | 歷史 |
| AKBAAkebia Therapeutics, Inc. | COM | 1,500,000 | $288.0 萬 | 0.5% | +1,500,000 | 新進 | 歷史 |
| MAZEMaze Therapeutics, Inc. | COM | 250,000 | $275.3 萬 | 0.4% | +250,000 | 新進 | 歷史 |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 241,957 | $274.6 萬 | 0.4% | +4,022+1.7% | 加碼 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 100,000 | $273.7 萬 | 0.4% | +60,000+150.0% | 加碼 | 歷史 |
| OACCUOaktree Acquisition Corp. III Life Sciences | UNIT 10/04/2029 | 250,000 | $259.5 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| GERNGeron Corp | COM | 1,500,000 | $238.5 萬 | 0.4% | −750,000−33.3% | 減碼 | 歷史 |
| MNPRMonopar Therapeutics | COM NEW | 62,000 | $225.7 萬 | 0.4% | +62,000 | 新進 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 49,692 | $223.9 萬 | 0.4% | −21,050−29.8% | 減碼 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 800,000 | $200.8 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 263,817 | $199.7 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 1,500,000 | $183.0 萬 | 0.3% | +1,000,000+200.0% | 加碼 | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM CL A | 394,159 | $169.5 萬 | 0.3% | +250,000+173.4% | 加碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 150,000 | $151.3 萬 | 0.2% | +150,000 | 新進 | 歷史 |
| NKTXNkarta, Inc. | COM | 800,000 | $147.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| AVRAnteris Technologies Global Corp. | COM | 390,000 | $142.0 萬 | 0.2% | +90,000+30.0% | 加碼 | 歷史 |
| MBXMBX Biosciences, Inc. | COM | 175,000 | $129.2 萬 | 0.2% | +175,000 | 新進 | 歷史 |
| THRDThird Harmonic Bio, Inc. | COM | 370,000 | $128.4 萬 | 0.2% | +370,000 | 新進 | 歷史 |
| ETNB89bio, Inc. | COM | 175,000 | $127.2 萬 | 0.2% | +175,000 | 新進 | 歷史 |
| ABVXAbivax S.A. | SPONSORED ADS | 200,000 | $125.0 萬 | 0.2% | +200,000 | 新進 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 325,000 | $122.2 萬 | 0.2% | +325,000 | 新進 | 歷史 |
| NXTCNextCure, Inc. | COM | 2,302,598 | $110.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| MGTXMeiraGTx Holdings plc | COM | 150,000 | $101.7 萬 | 0.2% | +150,000 | 新進 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 25,000 | $94.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 25,000 | $60.4 萬 | 0.1% | +25,000 | 新進 | 歷史 |
| STROSutro Biopharma, Inc. | COM | 752,722 | $49.0 萬 | 0.1% | +752,722 | 新進 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 660,589 | $40.4 萬 | 0.1% | −354,751−34.9% | 減碼 | 歷史 |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 250,000 | $38.8 萬 | 0.1% | −309,163−55.3% | 減碼 | 歷史 |
| RADXRadiopharm Theranostics Ltd | SPONSORED ADS | 64,600 | $31.1 萬 | <0.1% | −91,571−58.6% | 減碼 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 223,335 | $28.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| CMPXCompass Therapeutics, Inc. | COM | 130,807 | $24.9 萬 | <0.1% | +130,807 | 新進 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 667,516 | $20.8 萬 | <0.1% | +667,516 | 新進 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 200,000 | $19.7 萬 | <0.1% | +100,000+100.0% | 加碼 | 歷史 |
| ADGMAdagio Medical Holdings, Inc. | COM | 213,235 | $17.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| OMEROmeros Corp | COM | 9,958 | $8.19 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| ALLKAllakos Inc. | COM | 250,000 | $5.69 萬 | <0.1% | +250,000 | 新進 | 歷史 |
| QTTBQ32 Bio Inc. | COM | 27,777 | $4.58 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Rocket Pharmaceuticals, Inc.77313F114 | *W EXP 09/02/202 | 75,000 | $3,525 | <0.1% | 00.0% | 不變 | – |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $2,958 | <0.1% | 00.0% | 不變 | – |
選擇權（16 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | $2.24 億 | – |
| iShares Russell 2000 ETF464287655 | ETF | $5,985 萬 | – |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $4,055 萬 | – |
| AMGNAmgen Inc | Stock | – | $2,181 萬 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | – | $1,485 萬 |
| PTGXProtagonist Therapeutics, Inc | COM | – | $834.2 萬 |
| CORTCorcept Therapeutics Inc | COM | – | $799.5 萬 |
| VERAVera Therapeutics, Inc. | CL A | – | $636.5 萬 |
| EXELExelixis, Inc. | COM | – | $498.4 萬 |
| EWTXEdgewise Therapeutics, Inc. | COM | $440.0 萬 | – |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | $153.5 萬 | $204.3 萬 |
| MLYSMineralys Therapeutics, Inc. | COM | $317.6 萬 | – |
| IBRXImmunityBio, Inc. | COM | $308.5 萬 | – |
| CMPXCompass Therapeutics, Inc. | COM | $252.8 萬 | – |
| GALTGalectin Therapeutics Inc | COM NEW | $224.0 萬 | – |
| TRMLTourmaline Bio, Inc. | COM | – | $152.1 萬 |
2024 年第 4 季之後清倉（14 檔）
2024 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 4 季股數 | 2024 年第 4 季市值 | 2024 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| Coherus Biosciences Inc19249HAB9 | NOTE 1.500% 4/1 | – | $1,619 萬 | 2.5% | – |
| ARVNArvinas, Inc. | COM | 630,000 | $1,208 萬 | 1.9% | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 300,000 | $564.0 萬 | 0.9% | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 850,512 | $321.5 萬 | 0.5% | 歷史 |
| CGONCG Oncology, Inc. | COM | 100,000 | $286.8 萬 | 0.4% | 歷史 |
| TECXTectonic Therapeutic, Inc. | COM | 58,331 | $269.3 萬 | 0.4% | 歷史 |
| BBOTBridgeBio Oncology Therapeutics, Inc. | CL A ORD SHS | 250,000 | $262.5 萬 | 0.4% | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 50,000 | $159.6 萬 | 0.2% | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 1,000,000 | $158.0 萬 | 0.2% | 歷史 |
| NARIInari Medical, Inc. | Stock | 25,000 | $127.6 萬 | 0.2% | 歷史 |
| SVRASavara Inc | COM | 410,586 | $126.0 萬 | 0.2% | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 142,316 | $95.6 萬 | 0.1% | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 9,992 | $25.2 萬 | <0.1% | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 150,000 | $3.45 萬 | <0.1% | 歷史 |